Fibrodysplasia Ossificans Progressiva (FOP)
Also known as: FOP / Fibrodysplasia Ossificans Progressiva / Myositis ossificans progressiva, unspecified site / Myositis ossificans progressiva / Progressive myositis ossificans / Progressive myositis ossificans (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB05467 | Palovarotene | A selective agonist of retinoic acid receptor gamma (RARĪ³) used to reduce heterotopic ossification in patients with Fibrodysplasia Ossificans Progressiva (FOP). |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00683 | Midazolam | 1 | Completed | 1 |
DB12320 | Palovarotene | 1 | Completed | 2 |
DB18064 | Fidrisertib | 2 | Recruiting | 1 |
DB16379 | Garetosmab | 2 | Completed | 1 |
DB12320 | Palovarotene | 2 | Completed | 3 |
DB12320 | Palovarotene | 2 | Terminated | 1 |
DB11805 | Saracatinib | 2 | Recruiting | 1 |
DB16379 | Garetosmab | 3 | Recruiting | 1 |
DB16379 | Garetosmab | 3 | Withdrawn | 1 |
DB12320 | Palovarotene | 3 | Active Not Recruiting | 1 |
DB12320 | Palovarotene | 3 | Completed | 1 |